Lyso Gb3
Clinical Biochemistry
Sample and container requirements
Serum SST
Minimum volume required
100 μL serum
Special requirements
None
Patient preparation
None.
Sample viability
Turnaround time
28 days
Reference range
The lysoGB3 assay is intended as a screening assay to either initiate further investigation or to monitor a patients response to therapy. Therefore, there is not a reference range associated with this assay.
Clinical guidance
This assay provides a quantitative measurement of Lyso GB3 and is used as a screening tool to determine whether further enzyme analysis or genotyping is required where there is clinical suspicion of Fabry disease. It is also used to monitor the efficacy of enzyme repleacement therapy.
Notes
Images to go here
This information was last updated on 19 August 2026